Physician profile
Bethany Terrell
NPI 1427677079
$512.03
in general payments reported to CMS, 2019-2025
14 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Neurodevelopmental Disabilities (Pediatrics) provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $57.16 · 2023: $95.17 · 2024: $38.89 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $119.20 | 2023-2025 | Epidiolex |
| Sk Life Science, INC. | $94.46 | 2025 | |
| Acadia Pharmaceuticals INC | $41.49 | 2023-2025 | Daybue |
| Alexion Pharmaceuticals, INC. | $40.26 | 2022 | |
| Sarepta Therapeutics, INC. | $29.95 | 2023 | |
| Sequel Med Tech, LLC | $27.78 | 2025 | Twiist |
| Ucb, INC. | $26.25 | 2025 | Briviact |
| Neurelis, INC. | $24.47 | 2024 | Valtoco |
| Orchard Therapeutics North America | $23.24 | 2025 | Lenmeldy |
| Upsher-Smith Laboratories LLC | $22.61 | 2025 | |
| Abbvie INC. | $17.77 | 2023 | Botox |
| Livanova USA, INC. | $16.90 | 2022 | |
| Itf Therapeutics LLC | $14.42 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $13.23 | 2023 | Fycompa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.